UBS Upgrades Idenix Pharmaceuticals Inc. (IDIX) to Buy
Tweet Send to a Friend
UBS upgraded Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) from Neutral to Buy.
This article: 56 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 56 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
